Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Kunal Rai, Christopher Terranova et al.|Cell Reports|2020Cited by 70
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher Terranova, Kunal Rai, Ming Tang et al.|Cell Reports|2021Cited by 31
Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy ResistanceMayinuer Maitituoheti, Kunal Rai, Alvin Shi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 4
Abstract 6425: Functional roles of enhancers in immune microenvironment & immunotherapy responseKunal Rai, Manolis Kellis, Mayinuer Maitituoheti et al.|Cancer Research|2023Cited by 0